Adherence trajectory as an on-treatment risk indicator among drug-resistant TB patients in the Philippines.
Saved in:
| Title: | Adherence trajectory as an on-treatment risk indicator among drug-resistant TB patients in the Philippines. |
|---|---|
| Authors: | Huddart S; Center for Tuberculosis, University of California San Francisco, San Francisco, CA, United States of America.; Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, CA, United States of America., Geocaniga-Gaviola DM; Disease Prevention and Control Bureau, Department of Health, Manila, Philippines., Crowder R; Center for Tuberculosis, University of California San Francisco, San Francisco, CA, United States of America.; Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, CA, United States of America., Lim AR; Disease Prevention and Control Bureau, Department of Health, Manila, Philippines., Lopez E; Disease Prevention and Control Bureau, Department of Health, Manila, Philippines., Valdez CL; Disease Prevention and Control Bureau, Department of Health, Manila, Philippines., Berger CA; Center for Tuberculosis, University of California San Francisco, San Francisco, CA, United States of America.; Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, CA, United States of America., Destura R; University of the Philippines, National Institutes of Health, Manila, Philippines., Kato-Maeda M; Center for Tuberculosis, University of California San Francisco, San Francisco, CA, United States of America.; Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, CA, United States of America., Cattamanchi A; Center for Tuberculosis, University of California San Francisco, San Francisco, CA, United States of America.; Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, CA, United States of America., Garfin AMC; Disease Prevention and Control Bureau, Department of Health, Manila, Philippines. |
| Source: | PloS one [PLoS One] 2022 Nov 08; Vol. 17 (11), pp. e0277078. Date of Electronic Publication: 2022 Nov 08 (Print Publication: 2022). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1932-6203 |
|---|---|
| DOI: | 10.1371/journal.pone.0277078 |
